Poglajen, G., Zemljič, G., Cerar, A., Frljak, S., Jaklič, M., Androcec, V., & Vrtovec, B. (2019). Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure. Cell Transplant.
Citação norma ChicagoPoglajen, Gregor, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Martina Jaklič, Vesna Androcec, and Bojan Vrtovec. "Transendocardial CD34+ Cell Therapy Does Not Increase the Risk of Ventricular Arrhythmias in Patients With Chronic Heart Failure." Cell Transplant 2019.
Citação norma MLAPoglajen, Gregor, et al. "Transendocardial CD34+ Cell Therapy Does Not Increase the Risk of Ventricular Arrhythmias in Patients With Chronic Heart Failure." Cell Transplant 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.